Literature DB >> 34319833

Validity of a method for identifying disease subtypes that are etiologically heterogeneous.

Emily C Zabor1, Venkatraman E Seshan2, Shuang Wang3, Colin B Begg2.   

Abstract

A focus of cancer epidemiologic research has become the identification of risk factors that influence specific subtypes of disease, a phenomenon known as etiologic heterogeneity. In previous work we developed a novel strategy to cluster tumor markers and identify disease subtypes that differ maximally with respect to known risk factors for use in the context of case-control studies. The method relies on the premise that unsupervised k-means clustering will find candidate solutions that are closely aligned with the sought-after etiologically distinct clusters, which may not be true in the presence of clusters of tumor markers that are not related to risk of disease. In this article, we investigate in detail the ability of the method to identify the "true" clusters in the presence of clusters that are unrelated to risk factors, what we term "counterfeit" clusters. We find that our method works when the strength of structure is larger in the clusters that truly represent etiologic heterogeneity than in the counterfeit clusters, but when this condition is not met, or when there are many tumor markers that simply represent noise, the method will not find the correct solution without first performing variable selection to identify the tumor markers most strongly related to the risk factors. We illustrate the results using data from a breast cancer case-control study.

Entities:  

Keywords:  Cancer epidemiology; clustering; dimension reduction; disease subtypes; etiologic heterogeneity; polytomous logistic regression

Mesh:

Substances:

Year:  2021        PMID: 34319833      PMCID: PMC9425153          DOI: 10.1177/09622802211032704

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   2.494


  17 in total

1.  Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

Authors:  Colin B Begg; Emily C Zabor
Journal:  Am J Epidemiol       Date:  2012-08-24       Impact factor: 4.897

2.  Statistical analysis of molecular epidemiology studies employing case-series.

Authors:  C B Begg; Z F Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-03       Impact factor: 4.254

3.  Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.

Authors:  David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Daniel J Weisenberger; Peter W Laird; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan; Paul J Limburg
Journal:  J Natl Cancer Inst       Date:  2010-06-29       Impact factor: 13.506

4.  A conceptual and methodological framework for investigating etiologic heterogeneity.

Authors:  Colin B Begg; Emily C Zabor; Jonine L Bernstein; Leslie Bernstein; Michael F Press; Venkatraman E Seshan
Journal:  Stat Med       Date:  2013-07-16       Impact factor: 2.373

5.  A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.

Authors:  Molin Wang; Aya Kuchiba; Shuji Ogino
Journal:  Am J Epidemiol       Date:  2015-06-26       Impact factor: 4.897

6.  A comparison of statistical methods for the study of etiologic heterogeneity.

Authors:  Emily C Zabor; Colin B Begg
Journal:  Stat Med       Date:  2017-07-26       Impact factor: 2.373

7.  Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma.

Authors:  Audrey Mauguen; Emily C Zabor; Nancy E Thomas; Marianne Berwick; Venkatraman E Seshan; Colin B Begg
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

8.  Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.

Authors:  Louise A Brinton; Ashley S Felix; D Scott McMeekin; William T Creasman; Mark E Sherman; David Mutch; David E Cohn; Joan L Walker; Richard G Moore; Levi S Downs; Robert A Soslow; Richard Zaino
Journal:  Gynecol Oncol       Date:  2013-02-26       Impact factor: 5.482

9.  Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.

Authors:  Carmen J Marsit; Brock C Christensen; E Andres Houseman; Margaret R Karagas; Margaret R Wrensch; Ru-Fang Yeh; Heather H Nelson; Joseph L Wiemels; Shichun Zheng; Marshall R Posner; Michael D McClean; John K Wiencke; Karl T Kelsey
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

10.  Genomic investigation of etiologic heterogeneity: methodologic challenges.

Authors:  Colin B Begg; Venkatraman E Seshan; Emily C Zabor; Helena Furberg; Arshi Arora; Ronglai Shen; Jodi K Maranchie; Matthew E Nielsen; W Kimryn Rathmell; Sabina Signoretti; Pheroze Tamboli; Jose A Karam; Toni K Choueiri; A Ari Hakimi; James J Hsieh
Journal:  BMC Med Res Methodol       Date:  2014-12-22       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.